Connor, Clark & Lunn Investment Management Ltd.

Position in LAB — Standard Biotools Inc.

CIK 1596800 VANCOUVER, A1

Position in LAB

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$17,063

-$962,717 QoQ

Shares Held

20,809

-91.7% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#97

of 143 holders

Holding Since

Mar 2020

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $204,731,115 across 26 Medical Devices names. LAB ranks #26 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	869,131	$78,864,946
2	BSX	Boston Scientific Corp	1,467,148	$62,617,875
3	PHG	Koninklijke Philips NV	563,724	$15,327,654
4	SNN	Smith & Nephew PLC	487,774	$14,052,767
5	NVCR	NovoCure Ltd	661,280	$10,018,391
6	IRTC	iRhythm Holdings, Inc.	42,314	$5,033,250
7	AXGN	Axogen, Inc.	67,118	$3,100,180
8	VREX	Varex Imaging Corp	293,435	$3,060,526

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$17,063	20,809	-91.7%	Shares	Sole	2026-08-13
2021-12-31	$979,780	249,944	+2.4%	Shares	Sole	2022-02-10
2021-09-30	$1,608,724	244,116	+2146.8%	Shares	Sole	2021-11-12
2021-06-30	$66,928	10,865	-92.7%	Shares	Sole	2021-08-12
2021-03-31	$675,807	149,515	-49.0%	Shares	Sole	2021-05-13
2020-12-31	$1,759,542	293,257	+1.5%	Shares	Sole	2021-02-16
2020-09-30	$2,146,088	288,841	+136.5%	Shares	Sole	2020-11-12
2020-06-30	$489,717	122,124	-20.4%	Shares	Sole	2020-08-13
2020-03-31	$389,653	153,407	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.